Updates on HER2-Directed ADCs Across Solid Tumors - Episode 10
The Potential Role for HER2-Targeted ADCs in Earlier Treatment Lines
Vijayakrishna Gadi, MD, PhD, discusses the role of antibody-drug conjugates in a curative setting.
Video content above is prompted by the following:
- A discussion surrounding earlier treatment lines involving HER2-targeted ADCs.
Related Content:
